SEC Form 4 · accession 0001333277-18-000036
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sujal Shah
Officer — Chief Executive Officer · Director
Period of report
May 11, 2018
Accepted (ET)
May 15, 2018 · 8:08 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2018 | P | 5,000 | $10.65 | A | 90,000 | D |
Table II — derivative securities
No Table II lines on this filing.